[1] 周寄中,张黎,汤超颖.关于自主创新与知识产权之间的联动[J]. 管理评论, 2005,17(11):41-45
[2] Ho C. M. Access to Medicine in the Global Economy:International Agreements on Patents and Related Rights[M]. London:Ox-ford University Press, 2011
[3] Acharyya R., García-Alonso M. D. C. Income Based Price Ubsidies and Parallel Imports[J]. International Review of Economics and Finance, 2012,21(6):865-894
[4] 古祖雪,揭婕."TRIPS-plus"协定:特征、影响与我国的对策[J]. 求索, 2008,(8):137-139
[5] 朱工宇.与公共健康有关的TRIPS-plus条款研究——兼论国际知识产权立法的双边趋势[J]. 上海对外经贸大学学报, 2010,17(2):41-48
[6] 杨静.美国-智利与美国-新加坡自由贸易协定TRIPS-plus对我国的研究借鉴意义[J]. 中国公证, 2012,(1):33-36
[7] 余敏友,廖丽.简评TRIPS-Plus知识产权执法及其合法性[J]. 法学杂志, 2011,32(12):29-33
[8] 石现明.美式自由贸易协定TRIPS-PLUS条款对发展中国家药品获得权和生命健康权的影响与危害[J]. 兰州学刊, 2011, (1):75-81
[9] 杨静,朱雪忠.中国自由贸易协定知识产权范本建设研究——以应对TRIPS-plus扩张为视角[J]. 现代法学, 2013,35(2):149-160
[10] 梁意.论"超TRIPS"边境措施及其合法性问题——以< TPP知识产权草案 >为视角[J]. 国际商务:对外经济贸易大学学报, 2015,(2):95-105
[11] Hamed E., Mohammed E. TRIPS-Plus Implications for Access to Medicines in Developing Countries:Lessons from Jordan-United States Free Trade Agreement[J]. Journal of World Intellectual Property, 2007,10(10):438-475
[12] Kessomboon N., Limpananont J. Impact on Access to Medicines from TRIPS-Plus:A Case Study of Thai-US FTA[J]. The South-east Asian Journal of Tropical Medicine And Public Health, 2010,41(3):667-677
[13] Rehman H. A. India, TRIPS-plus Tree Trade Agreements and the Future of Access to Essential Medicines[J]. Information & Communications Technology Law, 2010,19(3):267-300
[14] Xiong P. Patents in TRIPS-Plus Provisions and the Approaches to Interpretation of Free Trade Agreements and TRIPS:Do They Affect Public Health?[J]. Journal of World Trade, 2012,74(1):155-186
[15] Ala M. U. A Firm-level Analysis of the Vulnerability of the Bangladeshi Pharmaceutical Industry to the TRIPS Agreement:Impli-cations for R&D Capability and Technology Transfer[J]. Procedia Economics and Finance, 2013,5:30-39
[16] Maskus K. E. Chen Y. Vertical Price Control and Parallel imports:Theory and evidence[J]. Review of International Economics, 2004,12(4):551-570
[17] Maskus K. E., Chen Y. Vertical Pricing and Parallel Imports[J]. Journal of International Trade and Economic Development, 2005,14(1):1-18
[18] Roy S., Saggi K. Equilibrium Parallel Import Policies and International Market Structure[J]. Journal of International Economics, 2012,87(2):262-276
[19] Frank M. L. Parallel Trade and Its Ambiguous Effects on Global Welfare[J]. Review of International Economics, 2012,20(1):177-185
[20] Mukherjee A., Zhao L. Profitable Parallel Trade in Unionized Markets[J]. Journal of Economics, 2012,107(3):267-276
[21] 周晓唯,白芸.版权平行进口立法取向的经济学分[J]. 国际贸易问题, 2012,(2):158-168
[22] Li C., Maskus K. E. The Impact of Parallel Imports on Investments in Cost-reducting Research and Development[J]. Journal of International Economics, 2006,68(2):443-455
[23] Li C., Robles J. Product Innovation and Parallel Trade[J]. International Journal of Industrial Organization, 2007,25(25):417-429
[24] Matteucci G., Reverberi P. Parallel Trade, Product Quality and Welfare[J]. Economic Letters, 2014,122(2):258-262
[25] Jelovac I., Bordoy C. Pricing and Welfare Implications of Parallel Imports in the Pharmaceuticals Industry[J]. International Jour-nal of Health Care Finance and Economics, 2005,5(1):5-21
[26] Grossman G. M., Lai L. C. Parallel Imports and Price Controls. The RAND Journal of Economics[J]. 2008,39(2):378-402
[27] Acharyya R., García-Alonso M. D. C. Parallel Imports, Innovations and National Welfare:Role of the Sizes of the Income Clas-ses and National Markets for Health Care[J]. Singapore Economic Review, 2008,53(1):1-23
[28] Acharyya R., García-Alonso, M. D. C. Parallel imports, Drug Innovation and International Patent Protection:A Policy Game[J]. The Journal of International Trade & Economic Development, 2012,21(6):865-894
[29] Brekke K. R., Holmås T. H., Straume O. R. Price Regulation and Parallel Imports of Pharmaceuticals[J]. Journal of Public Economics, 2015,129(12):92-105
[30] Ganslandt M., Maskus E. K. Parallel Imports of Pharmaceutical Products in the European Union[D]. World Bank Policy Research Working Paper, No.2630
[31] Ganslandt M., Maskus K. E. Parallel Imports and the Pricing of Pharmaceutical Products:Evidence from the European Union[J]. Journal of Health Economics, 2004,23(5):1035-1057
[32] Acharyya R., García-Alonso M. D. C. Self-interested Motives for International Income Redistribution and Access to Health Care Innovation[J]. European Journal of Political Economy, 2006,22(2):322-336
[33] 邓宏钟,谭跃进.基于复杂适应系统的自动建模方法研究[J]. 计算机仿真, 2002,19(6):46-48
[34] 李常洪,李敏强,寇纪淞.多Agent合作结构研究[J]. 管理科学学报, 2003,6(5):6-11
[35] 刘贞,张希良,何建坤.实验经济学中多主体博弈仿真框架研究[J]. 系统仿真学报, 2008,(24):6658-6663
[36] 李振华,赵黎明.企业合作竞争系统自组织演化的动力学模型[J]. 天津大学学报, 2006,39(s1):293-297
[37] 陈学海,孟卫东,胡大江.国际合资企业中机会主义行为的演化博弈[J]. 系统工程理论与实践, 2009,29(2):53-60
[38] 熊熊,武栋才,张永杰,等.商业银行——中小企业有限次重复博弈仿真[J]. 系统工程, 2009,(10):56-61
[39] 蒋国银,胡斌,王缓缓.基于Agent和进化博弈的服务商动态联盟协同管理策略研究[J]. 中国管理科学, 2009,17(2):8692
[40] 徐岩,胡斌,钱任.基于随机演化博弈的战略联盟稳定性分析和仿真[J]. 系统工程理论与实践, 2011,31(5):920-926
[41] 武蓝芬,余翔.专利产品平行进口政策的经济理论比较分析[J]. 科学学与科学技术管理, 2009,30(3):39-43
[42] Mussa M., Rosen S. Monopoly and Product Quality[J]. Journal of Economic Theory, 1978,18(2):301-317
[43] Cobb L., Zacks S. Applications of Catastrophe Theory for Statistical Modeling in the Biosciences[J]. Journal of the American Sta-tistical Association, 1985,80(392):793-802 |